Abstract
Purpose
Studies are still ongoing to determine whether Helicobacter pylori (HP) may affect the results of laparoscopic sleeve gastrectomy (LSG). The main research objectives were HP prevalence in patients with severe obesity and the effects of HP status on outcomes.
Patients and Methods
This multicenter retrospective study included patients with severe obesity who had LSG. The patients were grouped into three groups based on the HP status of preoperative endoscopic biopsies and postoperative specimen results: group I (negative HP), group II (eradicated HP), and group III (positive HP). The primary outcome was the overall postoperative morbidities.
Results
One thousand six hundred fifteen patients who underwent LSG for severe obesity were included in this study. Seven hundred fifty (46.4%) patients had negative HP, and 637 (39.4%) patients had eradicated HP, whereas 228 (14.1%) patients had positive HP. The antral and gastric body wall thickness was significantly noticed with positive HP. The groups had no significant differences regarding postoperative complication frequency, severity, and hospital mortality. The rates of gastric leakage in the three groups do not differ significantly. BMI > 50, gastropexy, gastric thickness, and antral resection were found to be independent risk factors for the occurrence of postoperative complications after LSG. There was no statistical significance as regards postoperative %TWL and %EWL among the three groups.
Conclusion
The early results of LSG do not appear to be impacted by HP’s status. The early postoperative course is unaffected by HP eradication anymore. Therefore, routine preoperative HP testing may not be as necessary, and management can be finished after LSG.
Graphical Abstract
Similar content being viewed by others
References
Sakran N, Raziel A, Goiten O, et al. Laparoscopic sleeve gastrectomy for morbid obesity in 3003 patients: results at a high-volume bariatric center. Obes Surg. 2016;26:2045–50.
Peterli R, Wölnerhanssen BK, Peters T. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA. 2018;319(3):255–65.
Stenard F, Iannelli A. Laparoscopic sleeve gastrectomy and gastroesophageal reflux. World J Gastroenterol. 2015;21(36):10348–57.
Benedix F, Poranzke O, Adolf D, et al. Obesity Surgery Working Group Competence Network Obesity. Staple line leak after primary sleeve gastrectomy-risk factors and mid-term results: do patients still benefit from the weight loss procedure? Obes Surg. 2017;27(7):1780–8.
Cesana G, Cioffi S, Giorgi R, et al. Proximal leakage after laparoscopic sleeve gastrectomy: an analysis of preoperative and operative predictors on 1738 consecutive procedures. Obes Surg. 2018;28(3):627–35.
Noel P, Nedelcu M, Gagner M. Impact of the surgical experience on leak rate after laparoscopic sleeve gastrectomy. Obes Surg. 2016;26(8):1782–7.
Aurora A, Khaitan L, Saber A. Sleeve gastrectomy and the risk of leak: a systematic analysis of 4,888 patients. Surg Endosc. 2012;26(6):1509–15.
Abdallah E, El Nakeeb A, Youssef T, et al. Impact of extent of antral resection on surgical outcomes of sleeve gastrectomy for morbid obesity (a prospective randomized study). Obes Surg. 2014;24(10):1587–94.
Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1 (8390) 1984;1311–1315.
Graham DY, Go MF. Helicobacter pylori: current status. Gastroenterology. 1993;105:279–82.
Pattison CP, Combs MJ, Marshall BJ. Helicobacter pylori and peptic ulcer disease: evolution to revolution to resolution. AJR Am J Roentgenol. 1997;168:1415–20.
Correa P, Houghton JM. Carcinogenesis of Helicobacter pylori. Gastroenterology. 2007;133:659–72.
Di Palma A, Alhabdan S, Maeda A, Chetty R, Serra S, Quereshy F, Jackson T, Okrainec A. Preoperative Helicobacter pylori screening and treatment in patients undergoing laparoscopic sleeve gastrectomy. Obes Surg. 2020;30(7):2816–20.
Abu Abeid A, Abeid SA, Nizri E, Kuriansky J, Lahat G, Dayan D. The association of Helicobacter pylori, eradication, and early complications of laparoscopic sleeve gastrectomy. Obes Surg. 2022;32(5):1617–23.
Taha-Mehlitz S, Mongelli F, Sykora M, Scheiwiller A, Diebold J, Metzger J. Gass JM Routine histopathologic examination of the resected specimen after laparoscopic sleeve gastrectomy - what can be expected? Acta Chir Belg. 2021;121(6):380–5.
Brownlee AR, Bromberg E, Roslin MS. Outcomes in patients with Helicobacter pylori undergoing laparoscopic sleeve gastrectomy. Obes Surg. 2015;25(12):2276–9.
Safaan T, Bashah M, Ansari W, et al. Histopathological changes in laparoscopic sleeve gastrectomy specimens: prevalence, risk factors, and value of routine histopathologic examination. Obes Surg. 2017;27(7):1741–9.
Keren D, Matter I, Rainis T, et al. Sleeve gastrectomy leads to Helicobacter pylori eradication. Obes Surg. 2009;19(6):751–6.
Ergin A, Çiyiltepe H, Karip AB, et al. The effect of Helicobacter pylori eradication on gastric wall thickness in patients undergoing laparoscopic sleeve gastrectomy. Obes Surg. 2021;31(9):4024–32.
Rossetti G, Moccia F, Marra T, et al. Does Helicobacter pylori infection have influence on outcome of laparoscopic sleeve gastrectomy for morbid obesity? Int J Surg. 2014;12(Suppl 1):S68-71.
Onzi TR, d’Acampora AJ, de Araújo FM, et al. Gastric histopathology in laparoscopic sleeve gastrectomy: pre- and post-operative comparison. Obes Surg. 2014;24:371–6.
Sapala JA, Wood MH, Sapala MA, et al. Marginal ulcer after gastric bypass: a prospective 3-year study of 173 patients. Obes Surg. 1998;8:505–16.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.
Brethauer SA, Kim J, el Chaar M, Papasavas P, Eisenberg D, Rogers A, Ballem N, Kligman M, Kothari S; ASMBS Clinical Issues Committee. Standardized outcomes reporting in metabolic and bariatric surgery. Surg Obes Relat Dis. 2015;11(3):489–506.
Di Lorenzo N, Antoniou SA, Batterham RL, et al. Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC. EASO and ESPCOP Surg Endosc. 2020;34(6):2332–58.
Schulman AR, Abougergi MS, Thompson CCH. Pylori as a predictor of marginal ulceration: a nationwide analysis. Obesity (Silver Spring). 2017;25(3):522–6.
Smelt HJM, Smulders JF, Gilissen LPL, et al. Influence of Helicobacter pylori infection on gastrointestinal symptoms and complications in bariatric surgery patients: a review and meta-analysis. Surg Obes Relat Dis. 2018;14(10):1645–57.
Brownlee AR, Bromberg E, Roslin MS. Outcomes in patients with Helicobacter pylori undergoing laparoscopic sleeve Gastrectomy. Obes Surg. 2015;25:2276–9.
Almazeedi S, Al-Sabah S, Alshammari D, et al. The impact of Helicobacter pylori on the complications of laparoscopic sleeve gastrectomy. Obes Surg. 2014;24:412–5.
Rawlins L, Rawlins MP, Teel D. Human tissue thickness measurements from excised sleeve gastrectomy specimens. Surg Endosc. 2014;28:811–4.
Susmallian S, Goitein D, Barnea R, et al. Correct evaluation of gastric wall thickness may support a change in staplers’ size when performing sleeve gastrectomy. IMAJ. 2017;19:351–4.
Elariny H, Gonzalez H, Wang B. Tissue thickness of human stomach measured on excised gastric specimens from obese patients. Surg Technol Int. 2005;14:119–24.
Yazar FM, Baykara M, Karaagaç M, et al. The role of conventional ultrasonography in the evaluation of antral wall thickness in obese patients. Obes Surg. 2016;26:2995–3000.
Author information
Authors and Affiliations
Contributions
Study conception and design: AEN, TK, AS, HMA, MA, MDD.
Acquisition of data: AER, AEN, HA, AZ, AS, MA, MDD, AZ, KS, TK, AMS, MMM, MES, ME.
Analysis and interpretation of data: AEN, HMA, AER, KS, MA, MES, ME, TK.
Critical revision of the manuscript: AEN, HMA, AS, MA, MES, ME, TK.
The manuscript has been seen and approved by all authors.
Corresponding author
Ethics declarations
Consent to Participate
Informed consent was obtained from all individual participants included in the study.
Competing Interests
The authors declare no competing interests.
Ethics Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This manuscript has not been submitted for publication in any other journal and will not subsequently be submitted for potential publication in another journal until a decision has been made, nor has it been published previously in any media.
Key Points
• HP is not related to increased early postoperative morbidities following LSG.
• The antral and gastric body wall thickness was significantly noticed with positive HP.
• Eradication of HP does not have an impact on surgical outcomes of LSG.
• Routine preoperative HP testing may have restricted value in LSG.
• HP management can be finished after LSG.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
El Nakeeb, A., Salem, A., El Sorogy, M. et al. Impact of Helicobacter pylori Status on Postoperative Morbidities After Laparoscopic Sleeve Gastrectomy in an Endemic Region (a Retrospective Multicentric Study). OBES SURG 34, 183–191 (2024). https://doi.org/10.1007/s11695-023-06961-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-023-06961-0